Skip to main content
AkademIndex

Products

For developers

AkademBasesoonOpen API for the ecosystem
← Back to work

Works cited by this work

194 works

Work: An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies

  1. The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy

    Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5

    Review article20257 citations
    ABI

  2. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

    Article20215 citations
    ABI

  3. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

    S. Vincent Rajkumar

    Article20224 citations
    ABI

  4. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors

    Xiangping Li, Jian Qu, Xin-Qi Teng +4

    Review article20233 citations
    ABI

  5. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

    Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani +33

    Article20213 citations
    ABI

  6. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos +80

    Review article20223 citations
    ABI

  7. Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

    Larysa Sanchez, Yucai Wang, David S. Siegel +1

    Review article20162 citations
    ABI

  8. Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

    Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Jihye Park +33

    Article20202 citations
    ABI

  9. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

    Mattia D’Agostino, David A. Cairns, Juan José Lahuerta +28

    Article20222 citations
    ABI

  10. Multiple myeloma

    Florent Malard, Paola Neri, Nizar J. Bahlis +5

    Review article20242 citations
    ABI

  11. Circulating immune cells and risk of osteosarcoma: a Mendelian randomization analysis

    Li Lan, Yeqi Sun, Jia Luo +1

    Article20242 citations
    ABI

  12. Plasma cell neoplasms and related entities—evolution in diagnosis and classification

    Falko Fend, Ahmet Doǧan, James R. Cook

    Review article20222 citations
    ABI

  13. Monoclonal Gammopathy of Undetermined Significance

    Wilson I. Gonsalves, S. Vincent Rajkumar

    Review article20222 citations
    ABI

  14. Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

    Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau +9

    Article20072 citations
    ABI

  15. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

    Joaquín Martínez‐López, Juan José Lahuerta, François Pépin +21

    Article20142 citations
    ABI

  16. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

    S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau +7

    Article20052 citations
    ABI

  17. High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes

    Yinlei Bai, Kwan Yeung Wong, Tsz Kin Fung +1

    Other20162 citations
    ABI

  18. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    Leo Rasche, Shweta S. Chavan, Owen Stephens +19

    Article20172 citations
    ABI

  19. Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

    Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra +5

    Review article20192 citations
    ABI

  20. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Elı́as Campo, Elaine S. Jaffe, James R. Cook +70

    Article20222 citations
    ABI

  21. High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

    Luca Bertamini, Stefania Oliva, Delia Rota‐Scalabrini +26

    Article20222 citations
    ABI

  22. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

    Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig +25

    Article20222 citations
    ABI

  23. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

    Tomáš Jelı́nek, Renata Bezděková, David Žihala +27

    Article20222 citations
    ABI

  24. Chromosomal defects in multiple myeloma

    Sarah E. Clarke, Kathryn A. Fuller, Wendy N. Erber

    Review article20242 citations
    ABI

  25. Genomic Classification and Individualized Prognosis in Multiple Myeloma

    Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu +34

    Article20242 citations
    ABI